Union is strength: antiviral and anti-inflammatory drugs for COVID-19
J. Jesús Naveja, Abraham Madariaga‐Mazón, Francisco Javier Flores‐Murrieta, Julio Granados‐Montiel, Marco A. Maradiaga‐Ceceña, Víctor Duarte-Alaniz, Maricruz Maldonado-Rodriguez, Jazmín García-Morales, Juan Pablo Senosiain-Peláez, Karina Martínez‐Mayorga
Topics & Concepts
RepurposingDrug repositioningCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trial2019-20 coronavirus outbreakDrug discoveryDrugComputational biologyCoronavirusMedicineDrug developmentBioinformaticsPharmacologyVirologyBiologyInfectious disease (medical specialty)PathologyDiseaseEcologyOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesinterferon and immune responses